| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 3-Jan-09 | | Total Revenue | 7,384,574 | 6,578,598 | 6,745,084 | 8,684,517 | | Cost of Revenue | 6,982,664 | 6,192,493 | 6,364,080 | 8,170,211 | | | Gross Profit | 401,910 | 386,105 | 381,004 | 514,306 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 311,605 | 356,408 | 321,972 | 361,993 | | Non Recurring | 27,124 | (11,296) | 13,786 | 749,455 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 63,181 | 40,993 | 45,246 | (597,142) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 660 | (660) | (671) | 1,336 | | Earnings Before Interest And Taxes | 63,841 | 40,333 | 44,575 | (595,806) | | Interest Expense | 7,433 | 6,085 | 6,950 | 15,659 | | Income Before Tax | 56,408 | 34,248 | 37,625 | (611,465) | | Income Tax Expense | 14,103 | 8,904 | 10,159 | (47,180) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 42,305 | 25,344 | 27,466 | (564,285) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 42,305 | 25,344 | 27,466 | (564,285) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $42,305 | $25,344 | $27,466 | ($564,285) |
|
0.31% Nasdaq 0.00%
Income Statement
